PRHSX - T. Rowe Price Health Sciences

Nasdaq - Nasdaq Delayed Price. Currency in USD
74.41
+0.20 (+0.27%)
As of 8:00PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close74.21
YTD Return27.95%
Expense Ratio (net)0.77%
CategoryHealth
Morningstar Rating★★★★★
Morningstar Risk RatingAverage
Last Cap Gain0.00
Net Assets11.91B
Beta (3y)0.88
Yield0.00%
Holdings Turnover24.90%
Last Dividend0.00
Inception DateDec 29, 1995
Average for CategoryN/A
  • 5 Healthcare Mutual Funds to Buy in 2018
    Zacks16 days ago

    5 Healthcare Mutual Funds to Buy in 2018

    Broadly encouraging economic conditions, favorable tax policies and a higher number of approvals from the FDA makes healthcare mutual funds a hotbed of money

  • Unemployment Rate Remains At 17-Year Low: 5 Fund Picks
    Zackslast month

    Unemployment Rate Remains At 17-Year Low: 5 Fund Picks

    Mutual funds from sectors, which witnessed strong job additions are considered a stable investment.

  • 5 Best-Performing Healthcare Mutual Funds in Q3
    Zacks2 months ago

    5 Best-Performing Healthcare Mutual Funds in Q3

    Broadly encouraging economic conditions, favorable policies and a higher number of approvals from the FDA makes healthcare mutual funds a hotbed of money.

  • Forbes6 months ago

    Investing With The Top Biotech Managers

    Biotech stocks have taken off since President Trump took office. Through the end of July, the iShares Biotech ETF is up almost 19%, well ahead of broader market benchmarks. If you are thinking of investing in biotech stocks after this rally, here's what you need to know.

  • Investopedia9 months ago

    Top 4 Healthcare Mutual Funds for 2017

    The healthcare sector is strong this year, despite earlier uncertainty over the ACA. Check out these top mutual funds if you're ready to invest.